medline.ch Respirationstrakt Neoplasie

	Genetic influence of PPAR-Î³ rs1801282 and MTRR rs162036 variants on non-small cell lung cancer risk in Egyptians. Discov Oncol Metwally YF, Zahran RF, El Sadda RR, Refaat S, Elsaid AM. PMID: 42096170 [PubMed]
	Imaging and AI in tertiary prevention of lung cancer: Narrative review and clinical perspectives. Multidiscip Respir Med Molfini Curci C, Morabito A, Pagliaro R, Perrotta F, Ottaiano A, Santone A, D'Agnano V, Mormile R, Gallipoli D'Errico A, Bianco A, Picone C. PMID: 42095808 [PubMed]
	GLUT1 rs1385129G>A Raised the Risk and Poor Prognosis of Lung Cancer: A Case-Control Study. Hum Mutat Li Z, Wang D, Chen J, Wu D, Tang S, Huang J, Deng Y, Wang X, Qiu F, Yang L, Lu J. PMID: 42094236 [PubMed - indexed for MEDLINE]
	Epigenetic inflammation signatures and lung cancer risk among never-smoking women: a nested case-control study. medRxiv Rahman ML, Gargapati A, Hurwitz LM, Hu W, Keil AP, Breeze CE, Chaturvedi A, Shi J, Cai Q, Yang G, Long J, Gao YT, Christiani DC, Rothman N, Zheng W, Shu XO, Wong JYY, Lan Q. PMID: 42094136 [PubMed]
	Orchestration of the tumor microenvironment by citrus flavonoids: from preclinical mechanisms to translational therapeutic. Front Immunol Ma S, Wang X, Li M, Wang W, Ren Y, Shen Y, Yang K, Zhang Z, Feng Z, Tang S. PMID: 42094009 [PubMed - indexed for MEDLINE]
	Rewiring the immune response in lung cancer: current progress in bispecific antibodies, CAR-T therapy, and the rise of in vivo CAR-T platforms. Front Immunol He L, Sun Y, Ma B, Lang G, Wen J, Blumenschein GR Jr, Ma H. PMID: 42093990 [PubMed - indexed for MEDLINE]
	Shuangshen granules enhance anti-PD1 therapy effectiveness in lung adenocarcinoma by modulating myeloid-derived suppressor cell-induced T cell exhaustion. Chin Med He ZN, Huang Q, Li Y, Hu JQ, Liu TT, Zhao YW, Ren XL, He SL, Li Y, Shi BL, Liu R, Guo QJ, Zhang X, Shi Z, He J, Qi RZ, Hua BJ. PMID: 42092980 [PubMed]
	The integrated analysis of PRDX3 in lung cancer: biomarker potential and therapeutic target prospects. Respir Res Kong Q, Zhang L, Gong S, Wu Y, Wang J. PMID: 42092925 [PubMed - as supplied by publisher]
	Relationship between the advanced lung cancer inflammation index (ALI) and all-cause and cause-specific mortality among patients with chronic obstructive pulmonary disease (COPD): a population-based study. BMC Pulm Med Luo Z, Chen P, Chen L, Ma H, Cao C. PMID: 42092873 [PubMed - as supplied by publisher]
	Association of Coronary Calcification or Vascular Inflammation and Cardiovascular Events and Prognosis in Non-small Cell Lung Cancer: A Retrospective Study. Respir Med Hayashi M, Fujimoto K, Endo J, Matsumoto-Miyazaki J, Kanamori H, Matsuo M, Okura H. PMID: 42092596 [PubMed - as supplied by publisher]
	Muscle loss and pentraxin-3 as predictors of immunotherapy outcomes in non-small cell lung cancer: a prospective study. Sci Rep Masuda T, Watanabe S, Suzuki R, Yanai K, Yamazaki R, Ando Y, Wakabayashi T, Tanaka S, Shono K, Yanagimura N, Sato M, Tanaka T, Nozaki K, Saida Y, Shima K, Kimura Y, Aoki N, Ohshima Y, Koya T, Sakai K, Nishio K, Yamazaki M, Ishikawa H, Kikuchi T. PMID: 42092113 [PubMed - as supplied by publisher]
	Low-dose radiotherapy synergizes with PD-1 blockade to achieve durable survival in advanced NSCLC through antitumor neutrophil programming. Signal Transduct Target Ther Zhou L, Liu Y, Xing Z, Wu Y, Yang X, Chen S, Kang K, Wang M, Zhou Z, Huang M, Gong Y, Zhou L, Zhou X, Li J, Yao Z, Zheng Q, Kong FS, Niedermann G, Luo R, Lu Y, Xue J. PMID: 42091852 [PubMed - indexed for MEDLINE]
	The global clinical trial landscape of lung cancer cellular therapy current status trends and scientific challenges. Discov Oncol Song C, Lu DS, Zhao CY, Xu ZY, Peng HJ, Li XL, Zeng HY, Li JH, Guo JJ, Yang N. PMID: 42091781 [PubMed - as supplied by publisher]
	Diagnostic Challenge in Treatment-Emergent Neuroendocrine Prostate Cancer: A Case Requiring Prostate Rebiopsy After an Inconclusive Metastatic Lung Biopsy. Intern Med Nakagaki S, Ito T, Sugiura K, Suzuki H, Morishita T, Taki S, Miyazawa A, Hayashi N, Hibino Y. PMID: 42091458 [PubMed - as supplied by publisher]
	Molecular Pathology of Lung Cancer. Surg Pathol Clin Lingard A, Dacic S. PMID: 42091274 [PubMed - indexed for MEDLINE]
	Immunotherapy Response and Survival Outcome by Immunophenotypic Signature in Non-Small Cell Lung Cancer. JCO Precis Oncol Bansal D, Ponvilawan B, Grachev D, Kushnarev V, Tarasov A, Valiev I, Danilov K, Butusova A, Turova P, Bagaev A, Kotlov N, Al-Obaidi A, Ward C, Subramanian J. PMID: 42090630 [PubMed - indexed for MEDLINE]
	Epidemiology and Real-World Outcomes in Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Mutant Non-small Cell Lung Cancer by Region: A Targeted Literature Review. Target Oncol Goto K, Hayashi H, Maruti SS, Zettl H, Mittal L, Pathak S, Le X. PMID: 42090048 [PubMed - as supplied by publisher]
	Semantic CT features and differentiation model: new primary lung cancer versus metastasis after previous malignancy. Eur Radiol Kalsi HS, Linton-Reid K, Kim C, Chen M, Crowe V, Alemu E, Mahboobani S, Gibeon D, Procter A, Hajhosseiny M, Owens C, Bartlett EC, Porta N, Thavaraja T, Doran S, Devaraj A, Sharma B, Nair A, Aboagye EO, Lee RW. PMID: 42089967 [PubMed - as supplied by publisher]
	The application and challenges of immune checkpoint inhibitors in lung cancer therapy. Front Immunol Li B, Ren Y, Zhang X. PMID: 42088497 [PubMed - indexed for MEDLINE]
	Efficacy and safety of local consolidative therapy combined with systemic therapy in driver-negative oligometastatic non-small cell lung cancer: a systematic review and meta-analysis. Front Oncol Han H, Li L, Park T, Yang Y, Alai G, Zhong C, Lin Y. PMID: 42088207 [PubMed]

Artikel 1 - 20 / 159365

Seite 1 von 7969



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung